Omalizumab: Clinical Use for the Management of Asthma
Omalizumab, a humanized monoclonal antibody that binds circulating IgE antibody, is a treatment option for patients with moderate to severe allergic asthma whose asthma is poorly controlled with inhaled corticosteroids and inhaled long-acting β 2 agonist bronchodilators. This review considers the me...
Main Authors: | Neil C. Thomson, Rekha Chaudhuri |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine |
Online Access: | https://doi.org/10.4137/CCRPM.S7793 |
Similar Items
-
Omalizumab: Clinical Use for the Management of Asthma
by: Neil C. Thomson, et al.
Published: (2012-06-01) -
Update on optimal use of omalizumab in management of asthma
by: Pelaia G, et al.
Published: (2011-06-01) -
Identification and management of adults with asthma prone to exacerbations: can we do better?
by: Chaudhuri Rekha, et al.
Published: (2008-12-01) -
Omalizumab for Severe Asthma: Beyond Allergic Asthma
by: C. C. Loureiro, et al.
Published: (2018-01-01) -
A review of omalizumab for the management of severe asthma
by: Lin CH, et al.
Published: (2016-07-01)